MedTrace Logo

NLR and PLR Levels Following PENG Block in Hip Arthroplasty

NCT07023107 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-29

No results posted yet for this study

Summary

Effect of PENG block on NLR and PLR following hip arthroplasty

Conditions

  • Hip Arthropathy
  • Hip Osteoarthritis
  • Hip Pain Chronic

Interventions

DRUG

0.9% Sodium Chloride Injection

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20ml of 0.9% sodium chloride

DRUG

Ropivacaine 0.2% Injectable Solution

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20 ml of 0.2% ropivacaine

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Malgorzata Reysner, M.D. Ph.D. · Poznan University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2025-12-09
Completion
2025-12-09

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07023107 on ClinicalTrials.gov